Patents by Inventor François Eleouet

François Eleouet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10774114
    Abstract: The invention provides polypeptides interacting with the binding of the RSV phosphoprotein P with the RSV nucleoprotein N and methods of using such polypeptides in the treatment and/or prevention of RSV infection.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: September 15, 2020
    Assignee: FONDATION THE ARK
    Inventors: Origéne Nyanguile, Jean-François Eleouet, Marie Galloux
  • Patent number: 10213413
    Abstract: The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: February 26, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE, Institut Pasteur, UNIVERSITÉ PARIS-SUD
    Inventors: Christina Sizun, Stéphane Duquerroy, Jean-François Eleouet, Felix Rey, Anny Slama Schwok, Didier Desmaele, Patrick Couvreur, Bogdan Tarus
  • Publication number: 20170360752
    Abstract: The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
    Type: Application
    Filed: November 5, 2015
    Publication date: December 21, 2017
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE, Institut Pasteur, UNIVERSITÉ PARIS-SUD
    Inventors: Christina Sizun, Stéphane Duquerroy, Jean-François Eleouet, Felix Rey, Anny Slama Schwok, Didier Desmaele, Patrick Couvreur, Bogdan Tarus
  • Publication number: 20170152292
    Abstract: The invention provides polypeptides interacting with the binding of the RSV phosphoprotein P with the RSV nucleoprotein N and methods of using such polypeptides in the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: March 10, 2015
    Publication date: June 1, 2017
    Inventors: ORIGÈNE NYANGUILE, JEAN-FRANÇOIS ELEOUET, MARIE GALLOUX
  • Patent number: 8252289
    Abstract: The invention relates to N protein-protein of interest fusion proteins, optionally in the form of soluble N protein-protein of interest/P protein complexes, the N and P proteins being proteins of a virus of the Paramyxoviridae family. When the protein of interest is an antigen, the invention relates also to vaccinal compositions and diagnostic reagents comprising those N protein-antigen fusion proteins or those N protein-antigen/P protein complexes. The N protein-protein of interest fusion protein can also be used as a “vector” for transporting into cells therapeutic molecules of interest, such as antivirals or anticancer agents.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: August 28, 2012
    Assignee: Institut National de la Recherche Agronomique (INRA)
    Inventors: Jean-François Eleouët, Sabine Riffault
  • Patent number: 8213454
    Abstract: A method and a system for managing the transmission of data streams by a terminal of a multiple-access shared communications network, said data streams being structured as data frames and comprising at least one priority data stream and at least one non-priority data stream. The method comprises the steps of determining a congestion state of said multiple-access shared network, and managing the transmission by said station of said priority and non-priority data streams as a function of said congestion state.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: July 3, 2012
    Assignee: France Telecom
    Inventors: Romain Insler, Joël Penhoat, François Eleouet
  • Patent number: 8071334
    Abstract: The invention relates to a method for preparation of soluble N-protein/truncated P-protein complex of a virus of the family Paramyxoviridae, complexes prepared thus and the soluble N-proteins which may be isolated from said complexes. The invention further relates to vaccine compositions comprising said N-protein/truncated P-protein complexes or N-proteins from Paramyxoviridae.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: December 6, 2011
    Assignee: Institut National de la Recherche Agronomique
    Inventors: Jean-Francois Eleouet, Sabine Riffault
  • Publication number: 20100021490
    Abstract: The invention relates to a method for preparation of soluble N-protein/truncated P-protein complex of a virus of the family Paramyxoviridae, complexes prepared thus and the soluble N-proteins which may be isolated from said complexes. The invention further relates to vaccine compositions comprising said N-protein/truncated P-protein complexes or N-proteins from Paramyxoviridae.
    Type: Application
    Filed: April 27, 2006
    Publication date: January 28, 2010
    Applicant: Institut National De La Recherche Agronomique (INRA)
    Inventors: Jean-Francois Eleouet, Sabine Riffault
  • Publication number: 20090219815
    Abstract: A method and a system for managing the transmission of data streams by a terminal of a multiple-access shared communications network, said data streams being structured as data frames and comprising at least one priority data stream and at least one non-priority data stream. The method comprises the steps of determining a congestion state of said multiple-access shared network, and managing the transmission by said station of said priority and non-priority data streams as a function of said congestion state.
    Type: Application
    Filed: December 22, 2006
    Publication date: September 3, 2009
    Inventors: Romain Insler, Joël Penhoat, Francois Eleouet
  • Publication number: 20090186337
    Abstract: The invention relates to N protein-protein of interest fusion proteins, optionally in the form of soluble N protein-protein of interest/P protein complexes, the N and P proteins being proteins of a virus of the Paramyxoviridae family. When the protein of interest is an antigen, the invention relates also to vaccinal compositions and diagnostic reagents comprising those N protein-antigen fusion proteins or those N protein-antigen/P protein complexes. The N protein-protein of interest fusion protein can also be used as a “vector” for transporting into cells therapeutic molecules of interest, such as antivirals or anticancer agents.
    Type: Application
    Filed: April 18, 2007
    Publication date: July 23, 2009
    Inventors: Jean-Francois Eleouet, Sabine Riffault